Accelerate to discover

Back to filter

Related topics

Feel empowered with new IncuCyte SX1 live cell analysis system

Sartorius

Jul 17, 2019

Today’s new normal requires doing more with less. You need physiologically relevant, information-rich cell analysis...

Linked-read sequencing advances understanding of cancers

Sage Science

Jul 8, 2019

Using Pippin HT to filter away smaller DNA fragments maximizes the efficiency of the whole genome linked-read...

BioFlux DCIS System, fully-integrated high content imaging under shear flow

Fluxion Biosciences

Jun 20, 2019

BioFlux DCIS is a fully-integrated high content screening platform for bridging the gap between in vitro and in vivo...

Fluxion Biosciences and National Cancer Institute cooperate to validate IsoFlux for sequencing

Fluxion Biosciences

Jun 12, 2019

Fluxion with IsoFlux has partnered with the Cleveland Clinic. They are aiming to improve sensitivity by timing the...

Jul 24, 2019

New insight into Cas9 off-target activity

LUMICKS

Jun 7, 2019

Scientists at the MRC London Institute of Medical Sciences and AstraZeneca studied how CRISPR-Cas9 differentiates...

A novel method for isolating high-quality UHMW DNA from animal and human tissues

BioNano Genomics

May 31, 2019

New isolation protocol for isolating high-quality UHMW DNA from 10 mg of freshly frozen or liquid-preserved animal and...

ParaVision 7 software

Bruker Biospin

May 27, 2019

The preclinical MRI software ParaVision 7 delivers unsurpassed image quality and enhanced productivity for both routine...

Jul 24, 2019

HLS-CATCH: Cas-9 assisted gene purification

Sage Science

May 24, 2019

The CATCH process  provides researchers with the most direct access to genes for study. Target regions are defined with...

Show all topics (10)

Attana enabled at University of Dublin

Jul 11, 2016

Under the supervision of Professor Kenneth A Dawson, the group at CBNI work with Nanomedicine and Nanosafety applications. The aim is to fundamentally understand the interactions between the nanoparticle interface and the biological milieu surrounding it. The milieu is set up by proteins and other biomolecules that forms the nanoparticle interface, the so-called “corona”. The corona forms the bionanointerface that determines the fate and behaviour of nanomaterials.

The group will use the Attana instruments to understand, classify and predict nanoparticle coronas physicochemical properties. This offers a novel approach to screen for toxicity at early stages of product development and for regulatory purposes.

“The Attana Cell 200 will be an important tool complementing our other techniques. We have a tradition of successfully implementing novel technologies into efficient research tools. The ability to perform kinetic interaction analysis between nanoparticles and cells add a crucial aspect in our research” comments Prof. Dawson.

Product news

Related technologies: Single-molecule Interactions

Brand profile

Attana

Attana biosensors provides a reliable, fast and versatile label-free method to study molecular interactions.

Related products

The label-free biosensor that combines biochemical and cell-based assays.

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey